STRYKER CORP Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
STRYKER CORP (SYK) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 29.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-02-11
- STRYKER CORP share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 29.10%, a 2.68% decline from fiscal 2024.
- STRYKER CORP share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 29.90%, a 3.10% increase from fiscal 2023.
- STRYKER CORP share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 29.00%, a 7.41% increase from fiscal 2022.
- STRYKER CORP share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 27.00%, a 0.37% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month as first filed |
|---|---|---|
| 2025-12-31 | 29.10% 10-K · filed 2026-02-11 | |
| 2024-12-31 | 29.90% 10-K · filed 2026-02-11 | |
| 2023-12-31 | 29.00% 10-K · filed 2026-02-11 | |
| 2022-12-31 | 27.00% 10-K · filed 2025-02-12 | |
| 2021-12-31 | 26.90% 10-K · filed 2024-02-14 | |
| 2020-12-31 | 18.90% 10-K · filed 2023-02-10 | |
| 2019-12-31 | 18.30% 10-K · filed 2022-02-11 | |
| 2018-12-31 | 16.80% 10-K · filed 2021-02-11 | |
| 2017-12-31 | 19.40% 10-K · filed 2020-02-06 | |
| 2016-12-31 | 20.50% 10-K · filed 2019-02-07 | |
| 2015-12-31 | 25.50% 10-K · filed 2018-02-08 | |
| 2014-12-31 | 26.30% 10-K · filed 2017-02-09 | 20.20% 10-K · filed 2015-02-12 |
| 2013-12-31 | 27.90% 10-K · filed 2016-02-11 | |
| 2012-12-31 | 27.60% 10-K · filed 2015-02-12 | |
| 2011-12-31 | 26.90% 10-K · filed 2014-02-13 | |
| 2010-12-31 | 28.60% 10-K · filed 2013-02-27 | |
| 2009-12-31 | 27.70% 10-K · filed 2012-02-13 | |
| 2008-12-31 | 22.70% 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |